InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,900.00
(
-2.65%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
77.36
(
0.00%
)
Bitcoin
61,773.88
(
0.57%
)
Post# of 252777
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: rkrw post# 90620

Monday, 02/15/2010 10:40:19 AM

Monday, February 15, 2010 10:40:19 AM

Post# of 252777
IP is a problem with Treands as Bendamustine was discovered and marketed in EU ages ago and has no CoM patent protection. It has 5 years of exclusivity due to Hatch-Waxman NCE regulations, plus as you know Cephalon is also trying to enhance Treanda IP and and several patent applications are pending at the USPTO.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up